55
Participants
Start Date
August 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
December 31, 2015
Methylphenidate
"Participants with epilepsy will first receive blinded, single-dose capsules which contain either:~Placebo 20mg of methylphenidate or 10mg of methylphenidate.~At each visit, they will receive one capsule and then complete the neurocognitive batteries and neuropsychiatric questionnaires. There will be no medication administered between visits during this time. Following the final randomized visit, interested participants will be prescribed 10mg of methylphenidate twice daily, to be increased to 20mg of methylphenidate twice daily. After four weeks, their scores on the batteries and questionnaires will again be assessed."
Stanford University, Palo Alto
Kimford Jay Meador
OTHER